Beta Thalassemia Resources

BT & Anemia

Role of anemia in BT

Treating anemia in BT

About REBLOZYL

REBLOZYL patient responses

Why REBLOZYL?

Starting &
Staying

Starting & staying on REBLOZYL

Starting REBLOZYL

Tracking your treatment

Resources

BT resources

Financial assistance

FAQ

Switch to REBLOZYL for MDS

References

This website is intended for U.S. residents 18 years of age or older.

REBLOZYL^® is a trademark of Celgene Corporation, a Bristol Myers Squibb company.

Access Support^® and Your REBLOZYL Connection™ are trademarks of Bristol-Myers Squibb Company.

REBLOZYL^® is licensed from Merck & Co. Inc., Rahway, NJ, USA and its affiliates.

© 2025 Bristol-Myers Squibb Company.

2007-US-2500017 1/25